A study co-led by Vinay Prasad, M.D., finds that more patients with cancer are eligible for immune checkpoint inhibitors; however, the ratio of those who benefit from the treatment is decreasing.

Gaurav Sahay, Ph.D., and Kelvin MacDonald, M.D., will use a new grant from the National Institutes of Health to develop an inhaled therapy for use by cystic fibrosis patients.

The health care journey of a patient who was referred to OHSU for treatment.

Dennis Bourdette, M.D., provides comment for a story about a New York lawsuit regarding financial incentive for prescribing drugs.

Aaron Caughey, M.D., Ph.D., discusses the “basics” of a C-section, including anesthesia, surgical processes and recovery.

In recognition of national skin cancer awareness month in May, Sancy Leachman, M.D., Ph.D., shares seven updates in melanoma and skin cancer prevention and detection.

The Daily Journal of Commerce reports on OHSU’s initial meeting with the Portland Design Commission regarding a potential hospital expansion; the article notes a second meeting will be held on June 27.

In a The New York Times (Parenting) article about birth options following cesarean section, Jeanne-Marie Guise, M.D., says: “I think it’s important to know that VBAC is an option for most women, and their chances of success are actually quite high.”

Vinay Prasad, M.D., M.P.H., and colleagues lead an independent review of all randomized clinical trials that culminated in FDA approval of new cancer drugs between January 2013 and July 2018.

An update on Providence Heart Institute’s efforts to revive their heart transplant program and an update from OHSU that its plans remains on track and it continues to "successfully recruit outstanding cardiologists" to join its existing team.